Clinical trial
Screening and Secondary Prevention Rheumatic Heart Disease
NCT05991219 is registered in ClinicalTrials.gov with National Institute of Cardiovascular Diseases, Pakistan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening and Secondary Prevention Rheumatic Heart Disease
- Lead sponsor
- National Institute of Cardiovascular Diseases, Pakistan
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 26, 2022
- Completion date
- December 31, 2028
- Enrollment
- 5,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.